Neuroimmunomodulating Oral Agents for Multiple Sclerosis: Neurodegeneration vs Neuroinflammation as Treatment Goals for MS
Chicago, IL(Pre-Registration Full)
Hilton Chicago
January 28, 2012
7:30 - 11:30 AM
3.5*
If you have any questions, please call
1-866-912-4726.
These programs are jointly Sponsored by CMEducation Resources, LLC and
the University of Massachusetts Medical School or the Postgraduate Institute of Medicine
